Tenpoint Therapeutics raises €7.6M Seed round
30 November 2020· London, United Kingdom· health, ophthalmology, biotech, cell_therapy, b2b, deep_hardware
Founding investment supported early operational development and technology expansion based on pioneering research from Moorfields Eye Hospital, UCL, and other global institutions.
Investors
LeadF-Prime Capital
Also participating
Sofinnova Partners
About Tenpoint Therapeutics
Stage
Series B
Headquarters
London, United Kingdom
Founded
2020
Team Size
51–200
Sectors
healthophthalmologybiotechcell_therapyb2bdeep_hardware